Episode 10 - Patient-Centered Approaches to Long-Term Prophylaxis in HAE - Part 3: Investigational Drugs for HAE Prophylaxis
カートのアイテムが多すぎます
カートに追加できませんでした。
ウィッシュリストに追加できませんでした。
ほしい物リストの削除に失敗しました。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
Episode 10 - Patient-Centered Approaches to Long-Term Prophylaxis in HAE - Part 3: Investigational Drugs for HAE Prophylaxis
-
ナレーター：
-
著者：
このコンテンツについて
Hereditary Angioedema (HAE) poses significant challenges for patients and healthcare providers alike, with recurrent attacks impacting quality of life and posing risks of severe complications. While advancements in treatment options have improved acute management, there remains unmet needs in the realm of long-term prophylaxis. In this podcast series, Dr. Timothy Craig and Dr. Marc Riedl will delve into the complexities of HAE management, focusing specifically on emerging solutions for long-term prophylaxis. Through their discussions, they provide insights into the challenges faced by patients with HAE, the limitations of current prophylactic options, and the potential avenues for innovation and improvement in the long-term management of HAE.
Launch Date: July 26, 2024
Release Date: July 26, 2024
Expiration Date: June 30, 2025
FACULTY
Timothy Craig, DO, FAAAAI, FACP, FACAAI, FACOI
Tenured Professor of Medicine
Pediatrics and Distinguished Educator
Pennsylvania State University
Marc Riedl, MD, MS
Professor of Medicine
University of California, San Diego
Clinical Director - US HAEA Angioedema Center
University of California, San Diego
This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided at this link below prior to listening to this
podcast.https://www.practicepointcme.com/CMEHome/patient-centered-approaches-to-long-term-prophylaxis-in-hae-1